Company profilePharmaceutical#671 of 1,318 in Pakistan✓ No DRAP alerts

SELMORE AGENCIES

Pharmaceutical company · 15 brands · 16 molecules

Ranked #93 of 101 companies in Antihistamines For Systemic Use

15 registered products 12 pharmaceutical brands 16 distinct molecules 0 DRAP alerts

Company overview

15
registered products
12
pharmaceutical brands
16
distinct molecules
2
therapeutic classes
0
DRAP alerts

SELMORE AGENCIES is a pharmaceutical manufacturer registered with the Drug Regulatory Authority of Pakistan, holding 15 product registrations across 16 distinct molecules. Its portfolio is concentrated in Antihistamines For Systemic Use and Neuro. It has no DRAP recall, shortage or safety notices on record.

Compiled from the DRAP registry, DRAP approved prices and DRAP alerts, with observed retail from DVAGO and Servaid. Data as of 2026-07-30.

Products by SELMORE

1 product matched in our catalogue — each with its observed price and DRAP approved ceiling.

Price ceiling age

DRAP sets a maximum price per registration and revises it only on application. In a market with high inflation, an old ceiling erodes margin in real terms.

1
ceilings with an approval date
0
not revised in 2+ years
2026
oldest approval year
20261

Top molecules by brand count

Atenolol1 brand
Diclofenac1 brand
Sertraline1 brand
Piroxicam-Beta-Cyclodextrin1 brand
Bisoprolol1 brand
Cetirizine1 brand
Paroxetine1 brand

Therapeutic classes

Antihistamines For Systemic Use · 1Neuro · 1

Conditions treated

Anxiety/Depression/Insomnia · 1

Price band (DRAP official ceilings)

Registered products priced by source
Servaid2 products · Rs 839.1 – Rs 1,111
Median across source: Rs 975.05

Regulatory record

No DRAP alerts on record

No recalls, shortage notices or safety alerts involving this company’s products appear in the DRAP alert feed we track. Median across all 1,318 mapped companies is zero — 1,165 of them also have a clean sheet.

Competitive set

Companies whose registered portfolio overlaps most with this one.

Portfolio whitespace

Molecules the closest competitors have registered and this company has not — the starting point for a launch shortlist.

BIO LABS (PVT) LTD. holds 139 molecules not in this portfolio
000 I.UAmlodipineAprepitantAremetherArtemetherArtesunate
Wilshire Laboratories (Private) Limited holds 133 molecules not in this portfolio
AcyclovirAcyclovir SodiumAlfacalcidolAmlodipineAmoxicillinAmoxycillin
GENOME PHARMACEUTICALS (PVT) LTD holds 112 molecules not in this portfolio
AcitretinAmlodipineAnastrazoleAnastrozoleAprepitantArtemether

Get the full profile for SELMORE

This page is a summary. The full company brief adds every registration with its approved ceiling and approval date, per-molecule competitive position, price positioning against the category, and a launch shortlist built from the whitespace above.

Request this brief See what’s included

Company data as of 2026-07-30. Brand and molecule counts from the DRAP registry and observed retail sources.

For medicine intelligence and professional reference only. Not medical advice.